News / Events

Press Releases

ImmuDyne Announces Strategic Blockchain-Linked Investment

NEW YORK, Nov. 27, 2017 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) (“ImmuDyne” or the “Company”), a leader in the development and online marketing of OTC health and wellness products addressing large unmet needs, today announced that it has made  a strategic investment and now owns 1,000,000 common shares of Blockchain Industries, Inc. (OTCMKTS:OMGT). 

“ImmuDyne believes that blockchain technologies have the ability to transform the online world. We think this specific strategic investment could be a fantastic windfall for all ImmuDyne shareholders, with very little proportionate risk. Additionally, our relationship with Blockchain Industries will give us a valuable partner and exposure to new companies and technologies that can support our core business of building and marketing innovative online proprietary brands,” stated Mark McLaughlin, CEO of ImmuDyne.

About ImmuDyne

ImmuDyne, Inc. (the "Company") is a health and wellness company that develops, manufactures, and markets innovative consumer products. ImmuDyne manufactures and markets a proprietary and patent protected Yeast Beta Glucan that has been shown in thousands of clinical studies to support and regulate the human immune system.  It has broad applications in skincare and as an immune support supplement.  ImmuDyne PR, a majority owned subsidiary of ImmuDyne, Inc., is the digital marketing arm of ImmuDyne and is currently focused on marketing products for thicker and fuller hair (Shapiro MD) and a skincare line containing ImmuDyne’s proprietary Yeast Beta Glucan ingredient (Inate MD).  All of lmmudyne's intellectual property is protected by patents and/or trade secrets. Additional information can be found on the web at www.immudyne.com

Forward-Looking Statements

Cautionary language regarding Forward-Looking Statements Safe Harbor Act Disclaimer: Forward­ looking statements in this release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Certain statements in this press release, including projections with respect to lmmuDyne's results of operations, may contain words such as "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "projects," "plans,"  "targets" and other similar language and are considered forward-looking statements. These statements are based on management's current expectations, estimates, and forecasts. These forward-looking statements are subject to important assumptions, risks and uncertainties, which are difficult to predict and therefore the actual results may be materially different from those discussed.

Investor Relations Contact:

Bernard Girma
+1-949-215-7754

Source: ImmuDyne, Inc.